Bio-Path Holdings, Inc. 8-K Report: Key Updates for Investors

$BPTH
Form 8-K
Filed on: 2025-02-18
Source
Bio-Path Holdings, Inc. 8-K Report: Key Updates for Investors

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Bio-Path Holdings, Inc.
  • CIK: 0001133818
  • Incorporation State: Delaware (DE)
  • SEC File Number: 001-36333
  • EIN: 87-0652870
  1. Address and Contact:
  • Address: 4710 Bellaire Boulevard, Suite 210, Bellaire, TX 77401
  • Phone Number: 832 742-1357
  1. Filing Details:
  • Filing Type: 8-K (a report of unscheduled material events or corporate changes)
  • Filing Date: February 14, 2025
  1. Securities Information:
  • Common Stock: Par value of $0.001 per share
  • Ticker Symbol: BPTH
  • Exchange: NASDAQ
  1. Period Covered:
  • Start Date: February 14, 2025
  • End Date: February 14, 2025

Insights:

  • The company is publicly traded on NASDAQ under the ticker BPTH, which indicates its accessibility to investors.
  • The filing type (8-K) suggests that there could be significant updates or events pertinent to investors occurring on the date of the report.
  • The entity is registered in Delaware, a common state for incorporation due to favorable corporate laws.

This information could be important for investors or analysts looking to understand recent developments or corporate actions related to Bio-Path Holdings, Inc.